Back to Search
JOSEPH MINGOIA, MD
MD
Psychiatry Physician
NPI: 1427374883Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
ME118836(FL)
Research & Publications (15)
Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction.
PMID 16126817·Am J Physiol Heart Circ Physiol·2006
7-preclinical
Selective targeting of matrix metalloproteinase inhibition in post-infarction myocardial remodeling.
PMID 16495760·J Cardiovasc Pharmacol·2006
4-observational
Chronic matrix metalloproteinase inhibition following myocardial infarction in mice: differential effects on short and long-term survival.
PMID 16757539·J Pharmacol Exp Ther·2006
7-preclinical
Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction.
PMID 16766634·Am J Physiol Heart Circ Physiol·2006
7-preclinical
Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity.
PMID 15723986·Circulation·2005
7-preclinical
Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction.
PMID 16129812·Circulation·2005
7-preclinical
Altered fibroblast function following myocardial infarction.
PMID 16111700·J Mol Cell Cardiol·2005
7-preclinical
Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function.
PMID 15820210·Cardiovasc Res·2005
7-preclinical
Myocyte contractility with caspase inhibition and simulated hyperkalemic cardioplegic arrest.
PMID 15111166·Ann Thorac Surg·2004
7-preclinical
Myocardial remodeling after discrete radiofrequency injury: effects of tissue inhibitor of matrix metalloproteinase-1 gene deletion.
PMID 14630637·Am J Physiol Heart Circ Physiol·2004
7-preclinical
Caspase inhibition attenuates contractile dysfunction following cardioplegic arrest and rewarming in the setting of left ventricular failure.
PMID 15550782·J Cardiovasc Pharmacol·2004
7-preclinical
Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
PMID 12975256·Circulation·2003
7-preclinical
Modulation of calcium transport improves myocardial contractility and enzyme profiles after prolonged ischemia-reperfusion.
PMID 14667641·Ann Thorac Surg·2003
7-preclinical
Pharmacologic inhibition of intracellular caspases after myocardial infarction attenuates left ventricular remodeling: a potentially novel pathway.
PMID 14688702·J Thorac Cardiovasc Surg·2003
7-preclinical
Direct inhibition of the sodium/hydrogen exchanger after prolonged regional ischemia improves contractility on reperfusion independent of myocardial viability.
PMID 14666024·J Thorac Cardiovasc Surg·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 EAST SHERIDAN RD
MELBOURNE, FL 32901 - Phone
- (321) 722-5200
Quick Facts
- NPI
- 1427374883
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 15
Are you this provider?
Claim Your Profile